Smith+Nephew announces redemption of $350m notes due 2027
The company issued a notice of redemption for the entire outstanding principal amount. The securities will be redeemed on October 5, 2026.
See the latest news and media coverage for Smith+Nephew. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company focused on tissue repair, regeneration and replacement
smith-nephew.comLast updated
In short: Smith+Nephew cut its annual outlook after weak US orthopaedics, while its J&J merger talks collapsed.
The company issued a notice of redemption for the entire outstanding principal amount. The securities will be redeemed on October 5, 2026.
John Rogers departs on September thirtieth for a new American position, while Pierre Palassian assumes the interim role until a permanent successor is appointed.
Smith+Nephew reported Q2 revenue of $1,597 million, up 1.6% underlying, and H1 trading profit of $566 million, up 8.1%. Full-year revenue growth guidance was lowered from 6% to 4%.
A PDMR transaction has been disclosed in compliance with regulations.
Smith & Nephew's talks with Johnson & Johnson to combine with the US group’s orthopaedics division ...
Smith & Nephew PLC.
Opinion change Change in opinion Add vs Buy Change in target price p 1,211 vs 1,444 -16.1% Along with the downgrades to our DCF and...
Smith & Nephew (SNN) has received US Food and Drug Administration 510 (k) clearance for its Landmark Total Knee System, the company said Tuesday. The...
Track Smith+Nephew and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Smith+Nephew and other trending companies.